Open AccessPhase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
Author(s) -
Hiroshi Asano,
Katsutoshi Oda,
Kosuke Yoshihara,
Yoichi M. Ito,
Noriomi Matsumura,
Muneaki Shimada,
Hidemichi Watari,
Takayuki Enomoto
Publication year - 2022
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2022.33.e55
Subject(s) - medicine , cohort , gynecologic oncology , oncology , leiomyosarcoma , clinical trial , adverse effect , chemotherapy , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom